EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

Explainable AI in Cancer Imaging: Scoping Review of Methods, Modalities, and Clinical Integration

Dimitris Fotopoulos, Ioannis Ladakis, Dimitrios Filos, Pedro A Moreno-Sánchez, Mark van Gils, Ioanna Chouvarda

Journal of Medical Internet Research · 20.05.2026 · 28 · e80645-e80645

DOI: 10.2196/80645 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Journal of Medical Internet Research, online erschienen am 20.05.2026. Verfasst von Dimitris Fotopoulos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Computing, Medical Informatics and Biomedical - Imaging Technologies, School of Medicine, Aristotle University of Thessaloniki, AUTh Ca…. Hauptthemen laut MEDLINE: Artificial Intelligence, Neoplasms, Diagnostic Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Explainable artificial intelligence (xAI) is increasingly used in medical imaging to enhance transparency, clinical interpretability, and trust in artificial intelligence (AI)–assisted diagnostics, particularly in oncology. Evidence on how explainability is implemented, validated, and reported in cancer imaging remains fragmented.

Objective

This scoping review aimed to systematically map research applying xAI methods to radiologic cancer imaging, summarize methodological and clinical trends, and identify persistent gaps in validation and integration.

Methods

We conducted a structured search of PubMed and Scopus (final search executed on October 20, 2025), covering studies published from 2017 to December 2024. Eligible peer-reviewed articles using machine learning or deep learning were analyzed with a focus on xAI components. Data from 371 studies were extracted into predefined categories covering cancer type, imaging modality, AI model, xAI method, terminology, validation, code availability, and decision support system integration.

Results

Studies focused primarily on breast (112/371, 30.2%), lung (87/371, 23.5%), and brain (56/371, 15.1%) cancers, with prostate, thyroid, and liver cancers also represented. The primary imaging modalities were computed tomography (139/371, 37.5%) and magnetic resonance imaging (104/371, 28%). Deep learning was used in 70.1% (260/371) of studies, classical machine learning in 18.1% (67/371), hybrid pipeline methods for 10% (37/371), and emerging concept-, prototype-, or causal-based approaches accounted for 1.9% (7/371) of studies. Post hoc xAI methods were dominant (305/371, 82.2%), with visualization (163/371, 53.4%), and feature relevance (111/371, 36.4%) as the most common subcategories. Hybrid post hoc or inherent approaches comprised 12.1% (45/371) and intrinsically interpretable methods 5.7% (21/371). Data sources were mostly public (149/371, 40.2%) or mixed (100/371, 26.9%); 22.9% (85/371) used private institutional datasets, and 7.8% (29/371) did not report data sources. Among validated studies, expert or user-based validation was most common (104/193, 53.9%), followed by mixed methods (74/193, 38.3%), while quantitative metrics (10/193, 5.2%) and clinical knowledge–based (8/193, 4.1%) validation remained rare. Only 17.5% (65/371) of studies provided code and 12.1% (45/371) reported decision support system integration, with few achieving actual clinical deployment.

Conclusions

This scoping review maps xAI implementation across multiple cancer imaging modalities, revealing methodological inconsistency and insufficient validation. Most research emphasizes visualization over quantitative interpretability, and few models are reproducible or clinically implemented. These findings provide an evidence base for researchers, clinicians, and regulators to prioritize standardization of xAI reporting, quantitative validation, and user-centered frameworks to advance trustworthy AI in oncology imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceNeoplasmsDiagnostic ImagingHumansMachine Learning

Stichwörter der Autor:innen

cancer imagingexplainable AImachine learningmedical imagingtrustworthiness

Autor:innen und Institutionen

  • Laboratory of Computing, Medical Informatics and Biomedical - Imaging Technologies, School of Medicine, Aristotle University of Thessaloniki, AUTh Campus, Thessaloniki, 54124, Greece, 30 2310999272.
  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Basque Research & Technology Alliance (BRTA), TECNALIA, Derio, Basque Country, Spain.

Zitieren

APA

Fotopoulos, D., Ladakis, I., Filos, D., Moreno-Sánchez, P. A., van Gils, M., & Chouvarda, I. (2026). Explainable AI in Cancer Imaging: Scoping Review of Methods, Modalities, and Clinical Integration. Journal of Medical Internet Research, 28, e80645-e80645. https://doi.org/10.2196/80645

Vancouver

Fotopoulos D, Ladakis I, Filos D, Moreno-Sánchez PA, van Gils M, Chouvarda I. Explainable AI in Cancer Imaging: Scoping Review of Methods, Modalities, and Clinical Integration. Journal of Medical Internet Research. 2026;28:e80645-e80645. doi:10.2196/80645

BibTeX
@article{Fotopoulos2026,
  author = {Fotopoulos, Dimitris and Ladakis, Ioannis and Filos, Dimitrios and Moreno-Sánchez, Pedro A and van Gils, Mark and Chouvarda, Ioanna},
  title = {Explainable AI in Cancer Imaging: Scoping Review of Methods, Modalities, and Clinical Integration},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e80645--e80645},
  doi = {10.2196/80645}
}
Kostenlos starten →